🇺🇸 FDA
Patent

US 9205044

Aqueous pharmaceutical preparation comprising roflumilast

granted A61KA61K31/44A61K47/10

Quick answer

US patent 9205044 (Aqueous pharmaceutical preparation comprising roflumilast) held by TAKEDA GMBH expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/44, A61K47/10, A61K47/12, A61K47/14